Senda Biosciences
Cambridge · Founded 2017
About Senda Biosciences
Senda Biosciences is a developer of therapeutic applications intended for novel treatments of human disease. The company studies the molecular relationships between bacterial, botanical, and human cells as well as how they define health and disease, providing medical professionals with novel medications and delivery methods. Senda Biosciences was established in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $309.0M
- Funding stage: M&A
- Last round: Series C (Aug 2022)
- Website: https://www.sendabiosciences.com/
- Phone: 617-430-4455
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/senda-biosciences-82837 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.